Treatment of recurrent and metastatic endometrial carcinoma with cisplatin and doxorubicin.

Abstract

Between April 1985 and February 1989, 19 patients with advanced or recurrent endometrial carcinoma were treated with the combination of cisplatin (50 mg/m2) and doxorubicin (50 mg/m2) administered intravenously every 21 days. Eight patients had Stage III disease, two had Stage IV and nine had recurrent cancer. Eleven patients had measurable disease at the… (More)

Topics

  • Presentations referencing similar topics